Preeclampsia: Pathophysiology and management

被引：84

作者：

Nirupama, R. ^{[1
]}

Divyashree, S. ^{[2
]}

Janhavi, P. ^{[2
]}

Muthukumar, Sp ^{[2
]}

Ravindra, Pv ^{[2
]}

机构：

[1] Penn State Coll Med, Dept Cellular & Mol Physiol, Hershey, PA USA

[2] CSIR CFTRI, Dept Biochem, Mysuru 570020, India

来源：

JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION | 2021年 / 50卷 / 02期

关键词：

Preeclampsia; Hypertension; Pregnancy complication; Placenta; Angiogenic-antiangiogenic factors; ANTI-ANGIOGENIC FACTORS; PLACENTAL GROWTH-FACTOR; ACTIVATE ANGIOTENSIN RECEPTORS; EARLY-ONSET PREECLAMPSIA; ELEVATED LIVER-ENZYMES; TYROSINE KINASE-1; AGONISTIC ANTIBODIES; MATERNAL AUTOANTIBODIES; CORTICOSTEROID-THERAPY; INTRAVENOUS LABETALOL;

D O I：

10.1016/j.jogoh.2020.101975

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Preeclampsia is a pregnancy-related multisystem disorder, frequently encountered pregnancy-related medical complications next to gestational diabetes mellitus. It is the onset of hypertension during pregnancy. The preeclampsia can be of two types, placental or maternal preeclampsia. Among these two types former, i.e., placental preeclampsia is more severe than the latter. According to the recent survey by National Health Portal of India, the incidence of preeclampsia is about 8-10 % among pregnant women. Though our understanding of preeclampsia has improved in recent years, the development and interpretation of the clinical tests remain difficult for preeclampsia. Hence, we have made an attempt to understand the pathophysiology, associated conditions/consequences, treatment and management/prevention of the condition in this review. (C) 2020 Published by Elsevier Masson SAS.

引用

页数：7

共 85 条

[51] Corticosteroid Therapy for Management of Hemolysis, Elevated Liver Enzymes, and Low Platelet Count (HELLP) Syndrome: A Meta-Analysis [J].

Mao, Minhong ;

Chen, Chen .

MEDICAL SCIENCE MONITOR, 2015, 21 :3777-3783

[52] Soluble fms-like tyrosine kinase 1 and endothelial dysfunction in the pathogenesis of preeclampsia [J].

Maynard, SE ;

Venkatesha, S ;

Thadhani, R ;

Karumanchi, SA .

PEDIATRIC RESEARCH, 2005, 57 (05) :1R-7R

[53] Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfimction, hypertension, and proteinuria in preeclampsia [J].

Maynard, SE ;

Min, JY ;

Merchan, J ;

Lim, KH ;

Li, JY ;

Mondal, S ;

Libermann, TA ;

Morgan, LP ;

Sellke, FW ;

Stillman, IE ;

Epstein, FH ;

Sukhatme, VP ;

Karumanchi, SA .

JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (05) :649-658

[54]

Muto Tsuyoshi, 2002, IDrugs, V5, P1141

[55] Oxidative stress in the placenta [J].

Myatt, L ;

Cui, XL .

HISTOCHEMISTRY AND CELL BIOLOGY, 2004, 122 (04) :369-382

[56] The Immunomodulatory Roles of Macrophages at the Maternal-Fetal Interface [J].

Nagamatsu, Takeshi ;

Schust, Danny J. .

REPRODUCTIVE SCIENCES, 2010, 17 (03) :209-218

[57] Serum and plasma determination of angiogenic and anti-angiogenic factors yield different results: The need for standardization in clinical practice [J].

Ogge, Giovanna ;

Romero, Roberto ;

Kusanovic, Juan Pedro ;

Chaiworapongsa, Tinnakorn ;

Dong, Zhong ;

Mittal, Pooja ;

Vaisbuch, Edi ;

Mazaki-Tovi, Shali ;

Gonzalez, Juan M. ;

Yeo, Lami ;

Hassan, Sonia S. .

JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2010, 23 (08) :820-827

[58] Soluble Endoglin, Transforming Growth Factor-Beta 1 and Soluble Tumor Necrosis Factor Alpha Receptors in Different Clinical Manifestations of Preeclampsia [J].

Perucci, Luiza O. ;

Gomes, Karina B. ;

Freitas, Leticia G. ;

Godoi, Lara C. ;

Alpoim, Patricia N. ;

Pinheiro, Melina B. ;

Miranda, Aline S. ;

Teixeria, Antonio L. ;

Dusse, Luci M. ;

Sousa, Lirlandia P. .

PLOS ONE, 2014, 9 (05)

[59] Soluble fms-Like Tyrosine Kinase 1 (sFlt1), Endoglin and Placental Growth Factor (PlGF) in Preeclampsia among High Risk Pregnancies [J].

Powers, Robert W. ;

Jeyabalan, Arun ;

Clifton, Rebecca G. ;

Van Dorsten, Peter ;

Hauth, John C. ;

Klebanoff, Mark A. ;

Lindheimer, Marshall D. ;

Sibai, Baha ;

Landon, Mark ;

Miodovnik, Menachem .

PLOS ONE, 2010, 5 (10)

[60] Characterization of a new selective antagonist for angiotensin-(1-7), D-Pro7-angiotensin-(1-7) [J].

Santos, RAS ;

Haibara, AS ;

Campagnole-Santos, MJ ;

Silva, ACSE ;

Paula, RD ;

Pinheiro, SVB ;

Leite, MD ;

Lemos, VS ;

Silva, DMR ;

Guerra, MT ;

Khosla, MC .

HYPERTENSION, 2003, 41 (03) :737-743

← 1 2 3 4 5 6 7 8 9 →